AJP - Heart AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (June 5, 2003). doi:10.1152/ajpheart.00165.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/H1675    most recent
00165.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, Y.-F.
Right arrow Articles by Yet, S.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, Y.-F.
Right arrow Articles by Yet, S.-F.
Submitted on February 19, 2003
Accepted on June 2, 2003

Identification of a CArG-independent region of the cysteine-rich protein 2 promoter that directs expression in the developing vasculature

Yung-Fu Chang1, Jiao Wei2, Xiaoli Liu2, Yen-Hsu Chen3, Matthew D. Layne2, and Shaw-Fang Yet2*

1 Pulmonary and Critical Care Division and Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; School of Biology, Kaohsiung Medical University, Kaohsiung, Taiwan, Taiwan
2 Pulmonary and Critical Care Division and Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
3 Pulmonary and Critical Care Division and Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Infectious Diseases and Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Taiwan

* To whom correspondence should be addressed. E-mail: syet{at}rics.bwh.harvard.edu.

Cysteine-rich protein (CRP) 2 is a member of the LIM-only CRP family that is expressed in vascular smooth muscle cells (VSMC). To gain insight into transcription of CSRP2 in VSMC, we analyzed the 5'-flanking sequence of the CSRP2 gene. We showed previously that 4855 bp of 5'-flanking sequence of the CSRP2 gene directed lacZ reporter gene expression primarily in the VSMC of transgenic mice. To further define the regulatory sequences important for CSRP2 expression in VSMC, a series of promoter constructs containing deletions of the 5'-flanking sequence upstream of a nuclear localized lacZ reporter were generated and analyzed. Similar to that observed in the -4855CSRP2-lacZ mice, {beta}-galactosidase reporter activity was detected in the developing great vessels, aorta, intersegmental arteries, umbilical vessels, endocardial cushions, and neural tube in the -3513, -2663, -795, and -664CSRP2-lacZ lines. However, an internal deletion of -573 to -550 bp abolished the vascular, but not the neural tube staining. Interestingly, no CArG-box (CC(A/T)6GG) was present in the -795 bp fragment. Cotransfection experiments showed that dominant negative serum response factor (DN-SRF) did not repress CSRP2 promoter activity, which was different from the repressive effect that DN-SRF has on the SM22{alpha} promoter. Our data suggest that VSMC-specific element(s) are present within -573 to -550 bp of the CSRP2 5'-flanking sequence; however, in contrast to many other smooth muscle genes, the transcriptional regulation of CSRP2 gene is not dependent on SRF.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. A. Lemmon and B. R. Wamhoff
"FRNKly, Smooth Muscle, I Don't Give a CArG!": A Novel Mechanism for Smooth Muscle Cell Differentiation
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2091 - 2093.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. L. Sayers, L. J. Sundberg-Smith, M. Rojas, H. Hayasaka, J. T. Parsons, C. P. Mack, and J. M. Taylor
FRNK Expression Promotes Smooth Muscle Cell Maturation During Vascular Development and After Vascular Injury
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2115 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
A. Avivi, L. Brodsky, E. Nevo, and M. R. Band
Differential expression profiling of the blind subterranean mole rat Spalax ehrenbergi superspecies: bioprospecting for hypoxia tolerance
Physiol Genomics, January 12, 2007; 27(1): 54 - 64.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Lindskog, E. Athley, E. Larsson, S. Lundin, M. Hellstrom, and P. Lindahl
New Insights to Vascular Smooth Muscle Cell and Pericyte Differentiation of Mouse Embryonic Stem Cells In Vitro
Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1457 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Wei, T. E. Gorman, X. Liu, B. Ith, A. Tseng, Z. Chen, D. I. Simon, M. D. Layne, and S.-F. Yet
Increased Neointima Formation in Cysteine-Rich Protein 2-Deficient Mice in Response to Vascular Injury
Circ. Res., December 9, 2005; 97(12): 1323 - 1331.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. P. Anderson, E. Dodou, A. B. Heidt, S. J. De Val, E. J. Jaehnig, S. B. Greene, E. N. Olson, and B. L. Black
HRC Is a Direct Transcriptional Target of MEF2 during Cardiac, Skeletal, and Arterial Smooth Muscle Development In Vivo
Mol. Cell. Biol., May 1, 2004; 24(9): 3757 - 3768.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.